ArticleFrontiers in neurology2025
Global burden trends of tension-type headache, 1990-2021: socio-demographic patterns, age-period-cohort effects, and frontier analysis from the GBD 2021 study.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Global Asthma Burden due to Attributable Risk Factors, 1990-2021, and Forecast to 2050: A Systematic Analysis of the Global Burden of Disease Study 2021.NPJ primary care respiratory medicine · 2026Article
- Sleep and Headache Disorders: What a Clinician Needs to Know.Current neurology and neuroscience reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Tension-type headache (TTH) is one of the most prevalent neurological disorders globally. While previous studies have examined TTH epidemiology across different regions, few have comprehensively analyzed how socio-demographic factors influence its patterns and trends. This study aimed to analyze TTH burden trends from 1990 to 2021 and their relationship with socio-demographic development. Methods: Data on prevalence, incidence, and years lived with disability (YLDs) for TTH were extracted from the Global Burden of Disease study (GBD) 2021, covering global, 5 SDI regions, 21 regions, and 204 countries. We used absolute numbers and age-standardized rates from 1990 to 2021. Spearman correlation assessed the relationship between rates and the Socio-Demographic Index (SDI). An age-period-cohort model disentangled temporal effects across different SDI levels, while frontier analysis evaluated improvement potential relative to SDI. Results: Despite modest decreases in age-standardized rates (prevalence: -0.56%, incidence: -0.32%, YLDs: -2.27%), absolute TTH cases reached 2.01 billion in 2021, increasing 56.4% from 1990. TTH burden showed moderate positive correlations with SDI, with High SDI regions having highest rates. Contrasting trends emerged: globally and in High and High-middle SDI regions rates decreased, while Middle SDI regions showed significant increases (prevalence: +5.83%). APC analysis revealed global peak prevalence at age 32.5 years, with period effects showing decreases in High SDI regions but increases in Middle SDI regions. Cohort effects indicated decreasing risks in recent High/High-middle SDI cohorts but increasing risks in Middle SDI regions. Conclusion: Our research reveals that TTH remains a substantial global health challenge, with its burden increasingly shifting toward younger populations in middle-income countries. This epidemiological transition, coupled with significant untapped potential for burden reduction even in high-SDI nations, demands the urgent development of context-specific public health strategies to mitigate the growing impact of this highly prevalent disorder.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.